Immediate flea and tick killing activity for up to and beyond the treatment period1
Not all parasiticides are created equally
SIMPARICA® brings a new innovative way to keep on top of fleas and ticks by providing immediate and persistent killing activity for at least 35 days1, acting beyond the monthly treatment period.
63% of UK pet owners confess to have given flea & tick medicine later than when it was due, with the median being 5 days late2
Simparica’s extended duration of activity helps minimise the potential risk of protection gaps.
Simparica® is a tasty chew for dogs that delivers new advances in flea, tick and mite control, helping to deliver improved client and patient satisfaction.
Simparica: Key Benefits
Simparica: Well tolerated in dogs
Safety information1
Age
Can be used in dogs from 8 weeks of age
Weight
Can be used in dogs from 1.3kg of bodyweight
Adverse Events
In very rare (less than 1 animal in 10,000 animals treated, including isolated reports) cases adverse reactions associated with mild and transient gastrointestinal effects such as vomiting and diarrhoea may occur. In very rare cases transient neurological disorders such as tremor, ataxia or convulsion may occur. These signs typically resolve without treatment.
Margin of Safety
In one overdose laboratory study, transient and self-limiting neurological signs were observed in some animals: mild tremors at 3 times the maximum exposure dose and convulsions at 5 times the maximum exposure dose. All dogs recovered without treatment.
Breeds
Simparica is well tolerated in Collies with a deficient multidrug-resistance-protein1 following single oral administration at 5 times the recommended dose.
Concurrent medication
Simparica may be used in combination with other routine veterinary medications, including milbemycin oxime, moxidectin and pyrantel pamoate (in these studies efficacy was not investigated).
The safety profile of Simparica was extensively studied in both laboratory and field studies, performed worldwide. These studies overall involved more than 3000 doses of Simparica administered to over 1500 dogs.
Simparica: Palatability
GREAT-TASTING PROTECTION:
Voluntary full consumption within one minute14
Simparica is a tasty, hard chewable tablet readily accepted by dogs
Can be given with or without food1
In European field studies Simparica was highly palatable with 93% of doses voluntarily consumed by client owned dogs within 1 minute of being offered
Simparica: The range
Bodyweight (kg)
Tablet strength (mg sarolaner)
Number of tablets to be administered
1.3 - 2.5
5
One
> 2.5 - 5
10
One
> 5 - 10
20
One
> 10 - 20
40
One
> 20 - 40
80
One
> 40 - 60
120
One
Want to know more about Simparica?
Request an appointment to speak to a Zoetis Account Manager
Thank you for submitting your request
A Zoetis Account Manager will be in contact shortly.
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.